# Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia

> **NCT00212381** · PHASE3 · COMPLETED · sponsor: **New York Presbyterian Hospital** · enrollment: 62 (estimated)

## Conditions studied

- Cervical Dysplasia

## Interventions

- **DRUG:** di indolylmethane (DIM)
- **DIETARY_SUPPLEMENT:** Red rice bran

## Key facts

- **NCT ID:** NCT00212381
- **Lead sponsor:** New York Presbyterian Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2006-01
- **Final completion:** 2010-07
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212381, "Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00212381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*